Global Transthyretin Market Growth 2022-2028

January 2022 | 98 pages | ID: GE7CA18C06F4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Transthyretin will have significant change from previous year. According to our (LP Information) latest study, the global Transthyretin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Transthyretin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Transthyretin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transthyretin market, reaching US$ million by the year 2028. As for the Europe Transthyretin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transthyretin players cover Alnylam Pharmaceuticals Inc, Arcturus Therapeutics Inc, Ionis Pharmaceuticals Inc, and Neurimmune Holding AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transthyretin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

• AG-10
• ALN-TTRsc02
• CRX-1008
• EDE-1307
• Inotersen Sodium
• Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

• Familial Amyloid Neuropathies
• Alzheimer's Disease
• Cardomyopathy
• Neuropathy
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

• Alnylam Pharmaceuticals Inc
• Arcturus Therapeutics Inc
• Ionis Pharmaceuticals Inc
• Neurimmune Holding AG
• Pfizer Inc
• Prothena Corp Plc
• Regeneron Pharmaceuticals Inc

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transthyretin Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Transthyretin by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Transthyretin by Country/Region, 2017, 2022 & 2028
2.2 Transthyretin Segment by Type
  2.2.1 AG-10
  2.2.2 ALN-TTRsc02
  2.2.3 CRX-1008
  2.2.4 EDE-1307
  2.2.5 Inotersen Sodium
  2.2.6 Others
2.3 Transthyretin Sales by Type
  2.3.1 Global Transthyretin Sales Market Share by Type (2017-2022)
  2.3.2 Global Transthyretin Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Transthyretin Sale Price by Type (2017-2022)
2.4 Transthyretin Segment by Application
  2.4.1 Familial Amyloid Neuropathies
  2.4.2 Alzheimer's Disease
  2.4.3 Cardomyopathy
  2.4.4 Neuropathy
  2.4.5 Others
2.5 Transthyretin Sales by Application
  2.5.1 Global Transthyretin Sale Market Share by Application (2017-2022)
  2.5.2 Global Transthyretin Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Transthyretin Sale Price by Application (2017-2022)

3 GLOBAL TRANSTHYRETIN BY COMPANY

3.1 Global Transthyretin Breakdown Data by Company
  3.1.1 Global Transthyretin Annual Sales by Company (2020-2022)
  3.1.2 Global Transthyretin Sales Market Share by Company (2020-2022)
3.2 Global Transthyretin Annual Revenue by Company (2020-2022)
  3.2.1 Global Transthyretin Revenue by Company (2020-2022)
  3.2.2 Global Transthyretin Revenue Market Share by Company (2020-2022)
3.3 Global Transthyretin Sale Price by Company
3.4 Key Manufacturers Transthyretin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Transthyretin Product Location Distribution
  3.4.2 Players Transthyretin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR TRANSTHYRETIN BY GEOGRAPHIC REGION

4.1 World Historic Transthyretin Market Size by Geographic Region (2017-2022)
  4.1.1 Global Transthyretin Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Transthyretin Annual Revenue by Geographic Region
4.2 World Historic Transthyretin Market Size by Country/Region (2017-2022)
  4.2.1 Global Transthyretin Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Transthyretin Annual Revenue by Country/Region
4.3 Americas Transthyretin Sales Growth
4.4 APAC Transthyretin Sales Growth
4.5 Europe Transthyretin Sales Growth
4.6 Middle East & Africa Transthyretin Sales Growth

5 AMERICAS

5.1 Americas Transthyretin Sales by Country
  5.1.1 Americas Transthyretin Sales by Country (2017-2022)
  5.1.2 Americas Transthyretin Revenue by Country (2017-2022)
5.2 Americas Transthyretin Sales by Type
5.3 Americas Transthyretin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Transthyretin Sales by Region
  6.1.1 APAC Transthyretin Sales by Region (2017-2022)
  6.1.2 APAC Transthyretin Revenue by Region (2017-2022)
6.2 APAC Transthyretin Sales by Type
6.3 APAC Transthyretin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Transthyretin by Country
  7.1.1 Europe Transthyretin Sales by Country (2017-2022)
  7.1.2 Europe Transthyretin Revenue by Country (2017-2022)
7.2 Europe Transthyretin Sales by Type
7.3 Europe Transthyretin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transthyretin by Country
  8.1.1 Middle East & Africa Transthyretin Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Transthyretin Revenue by Country (2017-2022)
8.2 Middle East & Africa Transthyretin Sales by Type
8.3 Middle East & Africa Transthyretin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transthyretin
10.3 Manufacturing Process Analysis of Transthyretin
10.4 Industry Chain Structure of Transthyretin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Transthyretin Distributors
11.3 Transthyretin Customer

12 WORLD FORECAST REVIEW FOR TRANSTHYRETIN BY GEOGRAPHIC REGION

12.1 Global Transthyretin Market Size Forecast by Region
  12.1.1 Global Transthyretin Forecast by Region (2023-2028)
  12.1.2 Global Transthyretin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transthyretin Forecast by Type
12.7 Global Transthyretin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Alnylam Pharmaceuticals Inc
  13.1.1 Alnylam Pharmaceuticals Inc Company Information
  13.1.2 Alnylam Pharmaceuticals Inc Transthyretin Product Offered
  13.1.3 Alnylam Pharmaceuticals Inc Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Alnylam Pharmaceuticals Inc Main Business Overview
  13.1.5 Alnylam Pharmaceuticals Inc Latest Developments
13.2 Arcturus Therapeutics Inc
  13.2.1 Arcturus Therapeutics Inc Company Information
  13.2.2 Arcturus Therapeutics Inc Transthyretin Product Offered
  13.2.3 Arcturus Therapeutics Inc Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Arcturus Therapeutics Inc Main Business Overview
  13.2.5 Arcturus Therapeutics Inc Latest Developments
13.3 Ionis Pharmaceuticals Inc
  13.3.1 Ionis Pharmaceuticals Inc Company Information
  13.3.2 Ionis Pharmaceuticals Inc Transthyretin Product Offered
  13.3.3 Ionis Pharmaceuticals Inc Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Ionis Pharmaceuticals Inc Main Business Overview
  13.3.5 Ionis Pharmaceuticals Inc Latest Developments
13.4 Neurimmune Holding AG
  13.4.1 Neurimmune Holding AG Company Information
  13.4.2 Neurimmune Holding AG Transthyretin Product Offered
  13.4.3 Neurimmune Holding AG Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Neurimmune Holding AG Main Business Overview
  13.4.5 Neurimmune Holding AG Latest Developments
13.5 Pfizer Inc
  13.5.1 Pfizer Inc Company Information
  13.5.2 Pfizer Inc Transthyretin Product Offered
  13.5.3 Pfizer Inc Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Pfizer Inc Main Business Overview
  13.5.5 Pfizer Inc Latest Developments
13.6 Prothena Corp Plc
  13.6.1 Prothena Corp Plc Company Information
  13.6.2 Prothena Corp Plc Transthyretin Product Offered
  13.6.3 Prothena Corp Plc Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Prothena Corp Plc Main Business Overview
  13.6.5 Prothena Corp Plc Latest Developments
13.7 Regeneron Pharmaceuticals Inc
  13.7.1 Regeneron Pharmaceuticals Inc Company Information
  13.7.2 Regeneron Pharmaceuticals Inc Transthyretin Product Offered
  13.7.3 Regeneron Pharmaceuticals Inc Transthyretin Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Regeneron Pharmaceuticals Inc Main Business Overview
  13.7.5 Regeneron Pharmaceuticals Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Transthyretin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transthyretin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AG-10
Table 4. Major Players of ALN-TTRsc02
Table 5. Major Players of CRX-1008
Table 6. Major Players of EDE-1307
Table 7. Major Players of Inotersen Sodium
Table 8. Major Players of Others
Table 9. Global Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Transthyretin Sales Market Share by Type (2017-2022)
Table 11. Global Transthyretin Revenue by Type (2017-2022) & ($ million)
Table 12. Global Transthyretin Revenue Market Share by Type (2017-2022)
Table 13. Global Transthyretin Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Transthyretin Sales Market Share by Application (2017-2022)
Table 16. Global Transthyretin Revenue by Application (2017-2022)
Table 17. Global Transthyretin Revenue Market Share by Application (2017-2022)
Table 18. Global Transthyretin Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Transthyretin Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Transthyretin Sales Market Share by Company (2020-2022)
Table 21. Global Transthyretin Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Transthyretin Revenue Market Share by Company (2020-2022)
Table 23. Global Transthyretin Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Transthyretin Producing Area Distribution and Sales Area
Table 25. Players Transthyretin Products Offered
Table 26. Transthyretin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Transthyretin Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Transthyretin Sales Market Share Geographic Region (2017-2022)
Table 31. Global Transthyretin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Transthyretin Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Transthyretin Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Transthyretin Sales Market Share by Country/Region (2017-2022)
Table 35. Global Transthyretin Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Transthyretin Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Transthyretin Sales Market Share by Country (2017-2022)
Table 39. Americas Transthyretin Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Transthyretin Revenue Market Share by Country (2017-2022)
Table 41. Americas Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Transthyretin Sales Market Share by Type (2017-2022)
Table 43. Americas Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Transthyretin Sales Market Share by Application (2017-2022)
Table 45. APAC Transthyretin Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Transthyretin Sales Market Share by Region (2017-2022)
Table 47. APAC Transthyretin Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Transthyretin Revenue Market Share by Region (2017-2022)
Table 49. APAC Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Transthyretin Sales Market Share by Type (2017-2022)
Table 51. APAC Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Transthyretin Sales Market Share by Application (2017-2022)
Table 53. Europe Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Transthyretin Sales Market Share by Country (2017-2022)
Table 55. Europe Transthyretin Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Transthyretin Revenue Market Share by Country (2017-2022)
Table 57. Europe Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Transthyretin Sales Market Share by Type (2017-2022)
Table 59. Europe Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Transthyretin Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Transthyretin Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Transthyretin Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Transthyretin Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Transthyretin Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Transthyretin Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Transthyretin Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Transthyretin Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Transthyretin Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Transthyretin
Table 70. Key Market Challenges & Risks of Transthyretin
Table 71. Key Industry Trends of Transthyretin
Table 72. Transthyretin Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Transthyretin Distributors List
Table 75. Transthyretin Customer List
Table 76. Global Transthyretin Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Transthyretin Sales Market Forecast by Region
Table 78. Global Transthyretin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Transthyretin Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Transthyretin Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Transthyretin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Transthyretin Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Transthyretin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Transthyretin Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Transthyretin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Transthyretin Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Transthyretin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Transthyretin Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Transthyretin Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Transthyretin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Transthyretin Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Transthyretin Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Transthyretin Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Transthyretin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Transthyretin Revenue Market Share Forecast by Application (2023-2028)
Table 96. Alnylam Pharmaceuticals Inc Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 97. Alnylam Pharmaceuticals Inc Transthyretin Product Offered
Table 98. Alnylam Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. Alnylam Pharmaceuticals Inc Main Business
Table 100. Alnylam Pharmaceuticals Inc Latest Developments
Table 101. Arcturus Therapeutics Inc Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 102. Arcturus Therapeutics Inc Transthyretin Product Offered
Table 103. Arcturus Therapeutics Inc Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. Arcturus Therapeutics Inc Main Business
Table 105. Arcturus Therapeutics Inc Latest Developments
Table 106. Ionis Pharmaceuticals Inc Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 107. Ionis Pharmaceuticals Inc Transthyretin Product Offered
Table 108. Ionis Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Ionis Pharmaceuticals Inc Main Business
Table 110. Ionis Pharmaceuticals Inc Latest Developments
Table 111. Neurimmune Holding AG Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 112. Neurimmune Holding AG Transthyretin Product Offered
Table 113. Neurimmune Holding AG Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Neurimmune Holding AG Main Business
Table 115. Neurimmune Holding AG Latest Developments
Table 116. Pfizer Inc Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 117. Pfizer Inc Transthyretin Product Offered
Table 118. Pfizer Inc Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Pfizer Inc Main Business
Table 120. Pfizer Inc Latest Developments
Table 121. Prothena Corp Plc Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 122. Prothena Corp Plc Transthyretin Product Offered
Table 123. Prothena Corp Plc Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Prothena Corp Plc Main Business
Table 125. Prothena Corp Plc Latest Developments
Table 126. Regeneron Pharmaceuticals Inc Basic Information, Transthyretin Manufacturing Base, Sales Area and Its Competitors
Table 127. Regeneron Pharmaceuticals Inc Transthyretin Product Offered
Table 128. Regeneron Pharmaceuticals Inc Transthyretin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. Regeneron Pharmaceuticals Inc Main Business
Table 130. Regeneron Pharmaceuticals Inc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Transthyretin
Figure 2. Transthyretin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transthyretin Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Transthyretin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transthyretin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AG-10
Figure 10. Product Picture of ALN-TTRsc02
Figure 11. Product Picture of CRX-1008
Figure 12. Product Picture of EDE-1307
Figure 13. Product Picture of Inotersen Sodium
Figure 14. Product Picture of Others
Figure 15. Global Transthyretin Sales Market Share by Type in 2021
Figure 16. Global Transthyretin Revenue Market Share by Type (2017-2022)
Figure 17. Transthyretin Consumed in Familial Amyloid Neuropathies
Figure 18. Global Transthyretin Market: Familial Amyloid Neuropathies (2017-2022) & (K Pcs)
Figure 19. Transthyretin Consumed in Alzheimer's Disease
Figure 20. Global Transthyretin Market: Alzheimer's Disease (2017-2022) & (K Pcs)
Figure 21. Transthyretin Consumed in Cardomyopathy
Figure 22. Global Transthyretin Market: Cardomyopathy (2017-2022) & (K Pcs)
Figure 23. Transthyretin Consumed in Neuropathy
Figure 24. Global Transthyretin Market: Neuropathy (2017-2022) & (K Pcs)
Figure 25. Transthyretin Consumed in Others
Figure 26. Global Transthyretin Market: Others (2017-2022) & (K Pcs)
Figure 27. Global Transthyretin Sales Market Share by Application (2017-2022)
Figure 28. Global Transthyretin Revenue Market Share by Application in 2021
Figure 29. Transthyretin Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Transthyretin Revenue Market Share by Company in 2021
Figure 31. Global Transthyretin Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Transthyretin Revenue Market Share by Geographic Region in 2021
Figure 33. Global Transthyretin Sales Market Share by Region (2017-2022)
Figure 34. Global Transthyretin Revenue Market Share by Country/Region in 2021
Figure 35. Americas Transthyretin Sales 2017-2022 (K Pcs)
Figure 36. Americas Transthyretin Revenue 2017-2022 ($ Millions)
Figure 37. APAC Transthyretin Sales 2017-2022 (K Pcs)
Figure 38. APAC Transthyretin Revenue 2017-2022 ($ Millions)
Figure 39. Europe Transthyretin Sales 2017-2022 (K Pcs)
Figure 40. Europe Transthyretin Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Transthyretin Sales 2017-2022 (K Pcs)
Figure 42. Middle East & Africa Transthyretin Revenue 2017-2022 ($ Millions)
Figure 43. Americas Transthyretin Sales Market Share by Country in 2021
Figure 44. Americas Transthyretin Revenue Market Share by Country in 2021
Figure 45. United States Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Transthyretin Sales Market Share by Region in 2021
Figure 50. APAC Transthyretin Revenue Market Share by Regions in 2021
Figure 51. China Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Transthyretin Sales Market Share by Country in 2021
Figure 58. Europe Transthyretin Revenue Market Share by Country in 2021
Figure 59. Germany Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Transthyretin Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Transthyretin Revenue Market Share by Country in 2021
Figure 66. Egypt Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Transthyretin Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Transthyretin in 2021
Figure 72. Manufacturing Process Analysis of Transthyretin
Figure 73. Industry Chain Structure of Transthyretin
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles